Table 1 Characteristics of the male study participants of the Heinz Nixdorf Recall (HNR) study.

From: Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study

Nb

2385 (100.0%)

Agea years

59.7 (± 7.8)

Educationb [10]

 ≤ 10 years

120 (5.1%)

11–13 years

1,135 (47.8%)

14–17 years

796 (33.5%)

 ≥ 18 years

324 (13.6%)

PCab

Prevalent at baseline

39 (1.64%)

Incident

143 (6.00%)

MGUSb

157 (6.58%)

Prevalent at baseline

98 (4.1%)

Incident

59 (2.5%)

Multiple myelomab (incident)

11 (0.46%)

Body mass index (kg/m2)a [12]

28.2 (± 4.0)

Physical activity (MET-hours/week)c [39]

35.0 (15.7–66.0)

Smokingb [5]

 

Never smoker

665 (27.9%)

Past smoker

1,104 (46.4%)

Current smoker

611 (25.7%)

Alcohol (g/week)c [42]

46.3 (6.9–118.6)

Diabetes mellitusb

473 (19.8%)

Total cholesterol (mg/dl)a [8]

224.7 (± 38.3)

LDL-cholesterol (mg/dl)a [16]

145.1 (± 35.5)

HDL-cholesterol (mg/dl)a [10]

51.0 (± 14.4)

Statin intakeb [171]

289 (13.1%)

High milk consumptionb [126]

655 (29.0%)

High yoghurt/quark consumptionb [104]

983 (43.1%)

High cheese consumptionb [84]

1,140 (49.5%)

High fruits consumptionb [41]

1,428 (60.9%)

High vegetable consumptionb

Raw [42]

588 (25.1%)

Cooked [40]

705 (30.1%)

High fish consumptionb [43]

820 (35.0%)

PCa in first degree relevants (family history)

69 (2.9%)

  1. MGUS monoclonal gammopathy of undetermined significance, PCa prostate cancer.
  2. aMean (± standard deviation).
  3. bNumber (%).
  4. cMedian (inter quartile range), [number of missing values].